Iwasawa, Yoshikazu
Departments of 1Oncology, 2Pharmacology, and 3Chemistry, Banyu Tsukuba Research Institute, Merck Research Laboratories, Tsukuba, Japan
2 papers on CoChat
Most cited papers
- Verified
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
Hirai, H., Iwasawa, Y., Okada, M., Arai, T., Nishibata, T., Kobayashi, M., Kimura, T., Kaneko, N., Ohtani, J., Yamanaka, K., et al. (2009) · Molecular Cancer Therapeutics
Cancer-related Molecular PathwaysDNA Repair Mechanisms
Cited by 540
- Verified
Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist: 1-[(3 R,4 R)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2 H-benzimidazol-2-one (J-113397)
Kawamoto, H., Ozaki, S., Itoh, Y., Miyaji, M., Arai, S., Nakashima, H., Kato, T., Ohta, H., & Iwasawa, Y. (1999) · Journal of Medicinal Chemistry
Neuropeptides and Animal PhysiologyReceptor Mechanisms and Signaling
Cited by 204
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free